9W8.F IKONISYS EO 2

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
1.34 EUR
Close of Nov 11, 2026
1.26 1.68
Market cap
EUR 21.2M
P/E
-
P/B
1.15x
ROE
-22.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 9W8.F undervalued?

Graham number

The Graham number of IKONISYS EO 2 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

IKONISYS EO 2 fundamental analysis

No fundamental analysis for IKONISYS EO 2 yet.

IKONISYS EO 2 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About IKONISYS EO 2

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that a…

Full company profile